stockportfolio.pro
Strata Critical Medical, Inc. (SRTA)
Healthcare · Medical Care Facilities · NasdaqCM
Strata Critical Medical, Inc. revenue & earnings — last 9 fiscal years
| Metric | 2019 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.20M | $0 | $23.43M | $0 | $50.53M | $146.12M | $225.18M | $146.82M | $197.14M |
| Gross profit | $4.70M | — | $2.33M | — | $10.52M | $22.27M | $42.12M | $29.59M | $41.13M |
| Net income | $-10.84M | $2.33M | $-10.16M | $-20.52M | $-40.05M | $-27.26M | $-56.08M | $-27.31M | $41.35M |
| Net margin | -34.7% | — | -43.4% | — | -79.3% | -18.7% | -24.9% | -18.6% | 21.0% |
Source: Strata Critical Medical, Inc. SEC filings (10-K).
Explore 9 years of Strata Critical Medical, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track SRTA in your portfolio →
Strata Critical Medical, Inc. financial history by metric
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Strata Critical Medical, Inc. — frequently asked questions
What is Strata Critical Medical, Inc.'s revenue?
Strata Critical Medical, Inc. (SRTA) reported revenue of $197.14M for fiscal year 2025, up 34.3% from the prior year, according to its SEC filings.
Is Strata Critical Medical, Inc. profitable?
Yes. SRTA earned net income of $41.35M in fiscal 2025, a net margin of 21.0%.
What is SRTA's P/E ratio?
Strata Critical Medical, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How much debt does Strata Critical Medical, Inc. have?
As of fiscal year 2025, SRTA carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Strata Critical Medical, Inc.'s gross margin?
SRTA's gross margin was 20.9% in fiscal 2025 — gross profit of $41.13M on revenue of $197.14M.
What is Strata Critical Medical, Inc.'s market cap?
Strata Critical Medical, Inc. (SRTA) has a market capitalization of about $467.24M, based on the latest data in our nightly-refreshed cache.
When does Strata Critical Medical, Inc.'s fiscal year end?
SRTA's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Strata Critical Medical, Inc.'s official SEC filings (10-K and 10-Q), covering 9 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.